Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01937221 · ClinicalTrials.gov registry record
Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 60
- Enrollment target
NCT01937221 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 60 participants.
The verdict
NCT01937221 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to create new retinal imaging processing software useful for the development of novel retinal biomarkers of cognitive impairment associated with Alzheimer's disease (AD).
Interventions
- OTHER spectral-domain optical coherence tomography (SD-OCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01937221
The ClinicalTrials.gov registry entry for NCT01937221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which spectral-domain optical coherence tomography (SD-OCT) is the first listed.
NCT01937221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01937221 about?
NCT01937221 is a clinical study titled "Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease". The goal of this study is to create new retinal imaging processing software useful for the development of novel retinal biomarkers of cognitive impairment associated with Alzheimer's disease (AD).
What is the current status of trial NCT01937221?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2013-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01937221?
The interventions under investigation include: spectral-domain optical coherence tomography (SD-OCT) (OTHER).
Who is sponsoring clinical trial NCT01937221?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.